Presolicitation: BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core
This pre-solicitation notice announces the intent to award multiple Indefinite Delivery/Indefinite Quantity contracts to provide DNA and RNA sequencing services in support of the BRAIN Initiative Cell Atlas Network. The National Institutes of Health National Institute on Drug Abuse seeks sequencing centers capable of large-scale single cell and bulk tissue transcriptome, epigenome, and multi-omics sequencing as well as whole genome and exome sequencing of libraries derived from isolated cells, nuclei, and bulk tissue from mammalian brains including human. Offerors must demonstrate the ability to perform high-throughput genomic and epigenomic sequencing and use standardized quality control and assurance methodologies to deposit high quality FASTQ files within 7-14 business days of receipt of libraries into a designated public data repository. The full solicitation will be issued on May 2, 2022 via SAM.gov.
There is no set-aside designation for this requirement. The primary NAICS code is 541715 and PSC code is R425. As this is a new requirement, there are no current incumbents. The potential performance period for any awarded contracts is 5 years, and contractors will provide sequencing services to support multiple research laboratories participating in the BRAIN Initiative Cell Atlas Network but specific award values or quantities are not included in this pre-solicitation notice.
75N95022R00031 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
4/15/22, 5:22 PM BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core
The National Institute of Mental Health seeks to award multiple Indefinite Delivery/Indefinite Quantity contracts to establish the BRAIN Initiative Cell Atlas Network Sequencing Core. This integrated network of DNA and RNA sequencing service providers will support the high-throughput genomic, epigenomic and transcriptomic sequencing needs of several research laboratories in the BRAIN Initiative Cell Atlas Network program. Awardees will perform sequencing of libraries derived from isolated cells, nuclei and bulk tissue from different brain regions of multiple mammalian species, with an emphasis on the human brain. Proposals are due by August 30, 2022 and will be evaluated based on technical approach, past performance, and pricing.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code Y299. The maximum total funding for all awardees is $149 million each over a seven-year period of performance from January 2023 through January 2030. Awardees will provide sequencing and data analysis services from laboratories in the United States to support genomic and transcriptomic research on samples delivered from various National Institutes of Health contracts and grants.
NIH-NIMH-75N95022R00031 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
7/13/22, 5:24 PM BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core
This notice seeks capability statements for large-scale RNA and DNA sequencing services as part of the National Institutes of Health BRAIN Initiative Cell Atlas Network Sequencing Core program. Interested parties must demonstrate the capability to receive libraries from NIH-funded laboratories and perform sequencing, quality control, and delivery of FASTQ files to an NIH repository. Capability statements not exceeding five pages are due by July 26, 2021 and will be evaluated based on the organization's technical qualifications, prior experience, and business information.
No set-aside is designated for this procurement. The NAICS code is 541714 for Research and Development in Biotechnology with a size standard of 1,000 employees. The total estimated value of multiple IDIQ contracts to be awarded is $150 million over five years, beginning September 1, 2022. Services will include sequencing of single-cell and bulk transcriptome and epigenome libraries from human, non-human primate, and mouse brain tissues totaling an estimated 5 trillion to 50 trillion sequencing reads annually to build NIH reference brain cell atlases.
NIDA-SSN-75N95021D00017 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
7/8/21, 3:28 PM NIH BRAIN Initiative: BRAIN Initiative Cell Atlas Network (BICAN)
This Special Notice was published by the National Institutes of Health National Institute on Drug Abuse seeking information from potential DNA sequencing service providers to support the BRAIN Initiative Cell Atlas Network (BICAN). Interested organizations are invited to submit responses with details on their capabilities to perform large-scale sequencing of single-cell and bulk tissue libraries from human, non-human primate and mouse brains to build reference atlases of brain cell types and variations. Responses are due by July 2, 2021 to inform project planning for this large-scale effort.
The purpose of this Special Notice is to identify sequencing providers and collect information on their capabilities, capacities, sample requirements, sequencing costs and turnaround times to support BICAN. Responses should include details on high-throughput sequencing operations and workflows, library types processed, data delivery options, quality assurance procedures, pricing structures and volumes achieved. Feedback is also requested on potential challenges in using centralized sequencing facilities and recommendations for mitigating issues. Responses are limited to ten pages and are due by July 2, 2021 to help the NIH assess alternatives for the potential sequencing requirement.
NIDA-RFI-75N95021D00017 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
6/17/21, 1:46 PM BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core
The Award Notice is for the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core. The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a multiple award Indefinite Delivery Indefinite Quantity contract worth a maximum combined total of $149 million to New York Genome Center, Inc. on January 30, 2023. The contract will support BICAN's efforts to map cell types in the brain and nervous system through sequencing services over an indefinite period of time.
75N95023D00007 Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse
1/31/23, 10:09 AM